We use strictly necessary cookies for the site to function (authentication, payments, security). We also use analytics cookies to understand how the site is used, but only with your permission. You can change your preferences at any time via the “Cookie preferences” link in the footer.

Chronic fatigue is one of the most common complaints in clinical practice, yet it remains poorly understood and frequently dismissed. When rest alone does not resolve persistent tiredness, a deeper investigation into cellular energy production — specifically mitochondrial function — may hold the key.
Mitochondria are the energy-producing organelles found in nearly every cell of the body. They convert nutrients from food into adenosine triphosphate (ATP), the molecule that powers cellular processes. When mitochondrial function is compromised, energy production drops and fatigue can become chronic.
Several factors can impair mitochondrial function:
A thorough evaluation of chronic fatigue should include, at minimum:
CoQ10 is critical for electron transport in the mitochondrial respiratory chain and also acts as an antioxidant. Levels tend to decline with age and with statin use. Supplementation in the range of 100–300 mg daily (often in the ubiquinol form for better absorption) has shown benefit in several trials and systematic reviews for reducing fatigue severity in selected populations.
The B-vitamin family — particularly thiamine (B1), riboflavin (B2), niacin (B3), pantothenic acid (B5), pyridoxine (B6), and methylcobalamin (B12) — acts as cofactors throughout the citric acid cycle and electron transport chain. Suboptimal B-vitamin status is common in patients with restricted diets, chronic gastrointestinal issues affecting absorption, or genetic variants such as MTHFR polymorphisms. Active forms (methylfolate, methylcobalamin, pyridoxal-5-phosphate) are preferred for patients who do not methylate efficiently, with typical clinical doses individualised based on testing rather than empirical dosing.
Magnesium is a cofactor for over 300 enzymatic reactions, including ATP production. Population studies suggest a substantial portion of UK adults consume below the reference nutrient intake of 270–300 mg daily. Magnesium glycinate and magnesium malate are well-tolerated forms commonly used clinically; doses of 200–400 mg in the evening can also support sleep architecture. Patients with renal impairment require medical supervision before supplementing.
Iron is essential for oxygen transport and mitochondrial cytochrome function. Ferritin levels below approximately 30 µg/L are increasingly recognised as functionally insufficient even in the absence of frank anaemia, particularly in menstruating women, athletes, and patients with restrictive eating patterns. Repletion strategies should be individualised; over-supplementation in patients with HFE genetic variants can be harmful, so testing before and during supplementation is essential.
Carnitine shuttles long-chain fatty acids into mitochondria for beta-oxidation. Several randomised trials report reductions in physical and mental fatigue with daily acetyl-L-carnitine supplementation in older adults and in selected post-viral fatigue presentations. Doses in the literature range widely; clinical use should be guided by symptom response and tolerability.
Sleep architecture. Mitochondrial repair is largely a nocturnal process. Aim for 7–9 hours, consistent sleep and wake times, low ambient light from sunset, and a cool bedroom. Continuous sleep tracking can identify fragmented patterns invisible to subjective recall.
Graded movement. Resistance training and brief, low-volume zone-2 cardio stimulate mitochondrial biogenesis. In post-exertional malaise presentations (e.g., ME/CFS, long-COVID), a graded, symptom-titrated approach is essential to avoid setbacks.
Stress and HPA-axis support. Chronic activation of the hypothalamic–pituitary–adrenal axis suppresses mitochondrial function via cortisol-mediated mechanisms. Daily breath-work, restorative practices, and protected recovery periods are not optional add-ons — they are clinical interventions.
Persistent fatigue with weight loss, lymphadenopathy, fevers, breathlessness, chest pain, or new neurological symptoms requires urgent medical assessment. Patients meeting criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) benefit from specialist input alongside nutritional and lifestyle support — NICE guideline NG206 should inform care planning. Functional medicine and conventional pathways are complementary, not competing.
Mitochondrial health is built daily through nutrient sufficiency, restorative sleep, intelligent movement, and stress regulation. Patients are best served by a structured assessment that maps their fatigue to specific physiological drivers rather than by trial-and-error supplementation. EPINUTRI practitioners use the Functional Health Matrix to coordinate this work — if rest alone has not been enough, a comprehensive assessment is the next step.
Written by

Medical disclaimer: The content in this article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making any changes to your health regimen. Individual results may vary. If you are experiencing a medical emergency, please contact 999 immediately.
EPINUTRI is opening to Chronic Fatigue practitioners in our early cohort. Apply to integrate the Functional Health Matrix into your practice.